Equities

Laboratory Corporation of America Holdings

Laboratory Corporation of America Holdings

Actions
  • Price (USD)199.59
  • Today's Change0.00 / 0.00%
  • Shares traded321.00
  • 1 Year change+4.81%
  • Beta--
Data delayed at least 20 minutes, as of Apr 26 2024 14:55 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Laboratory Corporation of America Holdings provides comprehensive laboratory services that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. By leveraging its unparalleled diagnostics and drug development capabilities, the Company provides insights and accelerates innovations to improve health and improve lives. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The Biopharma Laboratory Services segment consists of early development research laboratories and central laboratory services. The Company serves clients in more than 100 countries.

  • Revenue in USD (TTM)12.30bn
  • Net income in USD399.20m
  • Incorporated1994
  • Employees67.00k
  • Location
    Laboratory Corporation of America Holdings358 S MAIN STBURLINGTON 27215-5837United StatesUSA
  • Phone+1 (336) 229-1127
  • Fax+1 (302) 636-5454
  • Websitehttps://www.labcorp.com
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
LH:NYQ since
announced
Transaction
value
Baystate Health Inc-Outreach Laboratory businessAnnounced04 Oct 202304 Oct 2023Announced-1.03%--
Tufts Medicine-Outreach Laboratory BusinessDeal completed03 Aug 202303 Aug 2023Deal completed-7.70%--
Legacy Health System-Outreach Laboratory Select AssetsDeal completed11 Jul 202311 Jul 2023Deal completed-5.74%--
Providence Medical Group,Portland,Oregon-Outreach Laboratory businessDeal completed16 May 202316 May 2023Deal completed-10.99%--
Jefferson Health LLC-Outreach Laboratory businessAnnounced03 May 202303 May 2023Announced-12.19%--
Data delayed at least 15 minutes, as of Apr 26 2024 21:10 BST.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.